Is there a difference in the risk of hospital admission between BA.1 and BA.2 cases treated with Sotrovimab?

Researchers compared the risk associated with hospitalization of sotrovimab-treated individuals infected with SARS-CoV-2 Omicron variants.

Related Keywords

United Kingdom ,London ,City Of , ,United Kingdom Health Security Agency ,Digital Secondary Uses Service ,National Health Service ,Image Credit ,Secondary Uses Service ,Emergency Care Data Set ,Coronavirus Disease Covid 19 ,Hospital ,Otrovimab ,Coronavirus ,Covid 19 ,Efficacy ,Gene ,N Vitro ,Micron ,Protein ,Espiratory ,Cars ,Ars Cov 2 ,Evere Acute Respiratory ,Evere Acute Respiratory Syndrome ,Spike Protein ,Yndrome ,